These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23931100)

  • 1. Transcatheter left atrial appendage occlusion.
    Don CW; Fuller CJ; Reisman M
    Cardiol Clin; 2013 Aug; 31(3):363-84. PubMed ID: 23931100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y
    Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Atrial Appendage Transcatheter Occlusion with AMPLATZER™ Amulet™ Device: Real Life Data with Mid-Term Follow-Up Results.
    Şahiner ML; Kaya EB; Çöteli C; Aytemir K
    Arq Bras Cardiol; 2019; 113(4):712-721. PubMed ID: 31365601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
    Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
    BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Techniques for occlusion of the left atrial appendage: chances and risks].
    Goette A
    Nervenarzt; 2011 Feb; 82(2):172, 174-6, 178-9. PubMed ID: 21264461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation.
    Price MJ
    Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
    Block PC; Burstein S; Casale PN; Kramer PH; Teirstein P; Williams DO; Reisman M
    JACC Cardiovasc Interv; 2009 Jul; 2(7):594-600. PubMed ID: 19628179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage exclusion for atrial fibrillation.
    Syed FF; DeSimone CV; Friedman PA; Asirvatham SJ
    Cardiol Clin; 2014 Nov; 32(4):601-25. PubMed ID: 25443240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left atrial appendage occlusion: New perspectives for the method.
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.
    Bayard YL; Omran H; Neuzil P; Thuesen L; Pichler M; Rowland E; Ramondo A; Ruzyllo W; Budts W; Montalescot G; Brugada P; Serruys PW; Vahanian A; Piéchaud JF; Bartorelli A; Marco J; Probst P; Kuck KH; Ostermayer SH; Büscheck F; Fischer E; Leetz M; Sievert H
    EuroIntervention; 2010 Jun; 6(2):220-6. PubMed ID: 20562072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
    Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
    Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.